DNA Microarray Market Share, Trends And Growth By 2034

Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

What Is the Current Size and Annual Growth Rate of the DNA Microarray Market?
The dna microarray market size has grown rapidly in recent years. It will grow from $3.38 billion in 2024 to $3.78 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to pharmacogenomics, healthcare infrastructure development, collaborations and partnerships, cost reduction, and public awareness and education.

The dna microarray market size is expected to see rapid growth in the next few years. It will grow to " $5.82 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to growth in personalized medicine, the emergence of comparative genomic hybridization (CGH), expansion in agricultural genomics, regulatory approvals, and standards, and the rising prevalence of chronic diseases. Major trends in the forecast period include advancements in genomic research, increased funding for genomic studies, technological innovations, integration with other technologies, and technological advancements.

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16039&type=smp

Which Core Market Drivers Are Influencing the Development of the DNA Microarray Market?
The rapid adoption of personalized medicine is expected to propel the growth of the DNA microarray market. Personalized medicine tailors medical treatment to the individual characteristics of each patient, considering genetic, environmental, and lifestyle factors to optimize therapeutic efficacy and outcomes. Personalized medicine has emerged due to the rapid growth of 'omics' technology, data integration, genetics, and an awareness of the significance of tailored patient-specific medications and preventive actions. DNA microarrays enable personalized medicine by analyzing gene expression patterns, allowing tailored treatment plans based on an individual's genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 in 2022. Therefore, the rapid adoption of personalized medicine is driving the DNA microarray market.

Which Market Segment Offers the Most Significant Growth Opportunities in the DNA Microarray Market?
The dna microarraymarket covered in this report is segmented –

1) By Type: Complementary DNA Microarrays; Oligonucleotide DNA Microarrays; Other Types
2) By Application: Gene Expression Analysis; Genotyping; Other Applications
3) By End-user: Pharmaceutical And Biotechnology Companies; Diagnostic Centers; Hospitals And Clinics; Academic And Research Institute; Other End-Users

Subsegments:
1) By Complementary DNA Microarrays: Gene Expression Profiling; Comparative Genomic Hybridization (CGH); Quantitative Analysis
2) By Oligonucleotide DNA Microarrays: Gene Expression Microarrays; Single Nucleotide Polymorphism (SNP) Arrays; DNA Methylation Arrays; Pathogen Detection Arrays
3) By Other Types: Protein-DNA Microarrays; Tissue Microarrays; Affinity Microarrays; Spotted DNA Microarrays

Which Disruptive Trends Are Reshaping the Competitive Landscape of the DNA Microarray Market?
Major companies operating in the DNA microarray market are focusing on developing advanced technology that provides a two-day turnaround time to gain a competitive edge. Microarray analysis offers a two-day turnaround time, ensuring swift and efficient results. This rapid processing accelerates research and clinical decision-making. For instance, in August 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, introduced the Applied Biosystems CytoScan HD Accel array, a new chromosomal microarray aimed at enhancing productivity, efficiency, and profitability in cytogenetic research labs with a leading two-day turnaround time. The CytoScan HD Accel array performs whole-genome analysis with improved coverage in over 5,000 key genomic regions, delivering insights on chromosomal variants for diverse applications in prenatal, postnatal, and oncology research.

Who Are the Top Performers and Innovators in the DNA Microarray Market?
Major companies operating in the DNA microarray market are Roche Holding AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., bioMérieux SA, Schott AG, Bio-Rad Laboratories Inc., QIAGEN N.V., Bioneer Corporation, CapitalBio Technology Co. Ltd., Eurofins Genomics LLC, Savyon Diagnostics Ltd., Oxford Gene Technology, Sengenics Corporation LLC, Affymetrix, BioCat GmbH, Scienion AG, LC Sciences, Arrayit Corporation, Akonni Biosystems Inc., Arraystar Inc., Febit Holding GmbH

Get the detailed dna microarray market report today
https://www.thebusinessresearchcompany.com/report/dna-microarray-global-market-report

Which Regional Markets Are Likely to See the Most Significant Expansion in the Coming Years?
North America was the largest region in the DNA microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company